Danforth Advisors

Experienced, flexible and scalable – we cover wide-ranging needs in a capital efficient way

Our singular focus on the life science sector shapes our knowledge, perspective, capabilities and connections

We speak the language

The vernacular, cadence of product development and nuances of distinct therapeutic areas

We understand the journey

Clinical trials, regulatory cycles, milestones and capital needs

We know the community

Life science investors, bankers, attorneys, CROs and other pillars of the ecosystem

We contribute to the end game

Whether through commercialization, acquisition or other path, we position life science companies for their best possible outcomes We proudly partner with innovators whose work can change lives

Podcast Interview: How Biotechs Can Navigate Through Tough Financial Times

Danforth Advisors Acquires Argot Partners

Danforth Advisors Promotes Wendy Nelson to Chief Business Officer